Personal information

Verified email addresses

cancer chemotherapy toxicities
Brazil

Activities

Employment (1)

Universidade Federal do Ceará: Fortaleza, CE, BR

2011-02-04 to present | Professor (Department of Physiology and Pharmacology)
Employment
Source: Self-asserted source
Roberto CP Lima-Júnior

Education and qualifications (1)

Universidade Federal do Ceará: Fortaleza, CE, BR

2005-01-01 to 2008-07-11 | Ph.D. (Department of Physiology and Pharmacology)
Education
Source: Self-asserted source
Roberto CP Lima-Júnior

Works (3)

Is There an Interplay between Environmental Factors, Microbiota Imbalance, and Cancer Chemotherapy-Associated Intestinal Mucositis?

Pharmaceuticals
2024-08 | Journal article | Author
Contributors: Camila Fernandes; Mahara Coelho Crisostomo Miranda; Cássia Rodrigues Roque; Ana Lizeth Padilla Paguada; Carlos Adrian Rodrigues Mota; Katharine Gurgel; Anamaria Falcão Pereira; Deysi Wong; Reinaldo Barreto Oriá; Roberto CP Lima-Júnior
Source: check_circle
Multidisciplinary Digital Publishing Institute

Circulating let-7e-5p, miR-106a-5p, miR-28-3p, and miR-542-5p as a Promising microRNA Signature for the Detection of Colorectal Cancer

Cancers
2021-03 | Journal article | Author
Contributors: Camila Meirelles S. Silva; Mateus Barros Filho; Deysi Wong; Julia Bette H. Mello; Livia Maria S. Nobre; WANDERLEY CW; WANDERLEY CWS; WANDERLEY, CARLOS WAGNER DE SOUZA;; Larisse T. Lucetti; Heitor A. Muniz; Igor Kenned D. Paiva; Hellen Kuasne et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

The Alpha-Lipoic Acid Improves Survival and Prevents Irinotecan-Induced Inflammation and Intestinal Dysmotility in Mice

Pharmaceuticals
2020-11 | Journal article | Author
Contributors: Daniely V. S. Costa; Deiziane V. S. Costa; Caren N. S. Sousa; Angeline M. H. P. Silva; Ingridy S. Medeiros; Dainesy S. Martins; Conceição S. Martins; Ana Luiza Viana; Roberto CP Lima-Júnior; Pedro M. G. Soares et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Peer review (2 reviews for 2 publications/grants)

Review activity for Cancer chemotherapy and pharmacology. (1)
Review activity for Cell death discovery. (1)